Login / Signup

Evaluation of a novel blood microsampling device for clinical trial sample collection and protein biomarker analysis.

Jinming XingJoseph J LoureiroMichael T PatelDmitri MikhailovArkady I Gusev
Published in: Bioanalysis (2020)
Aim: Evaluation of a novel microsampling device for its use in clinical sample collection and biomarker analysis. Methodology: Matching samples were collected from 16 healthy donors (ten females, six males; age 42 ± 20) via K2EDTA touch activated phlebotomy (TAP) device and phlebotomy. The protein profile differences between sampling groups was evaluated using aptamer-based proteomic assay SomaScan and selected ELISA. Conclusion: Somascan signal concordance between phlebotomy- and TAP-generated samples was studied and comparability of protein abundances between these blood sample collection methods was demonstrated. Statistically significant correlation in selected ELISA assays also confirmed the TAP device applicability to the quantitative analysis of protein biomarkers in clinical trials.
Keyphrases
  • clinical trial
  • protein protein
  • high throughput
  • binding protein
  • randomized controlled trial
  • high resolution
  • open label
  • mass spectrometry
  • small molecule
  • double blind
  • quantum dots